{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:35:30Z","timestamp":1790804130924,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The ontogeny and evolution of chronic lymphocytic leukemia (CLL) are critically dependent on interactions between leukemic cells and their microenvironment, including antigens, the latter recognized through the clonotypic B-cell receptor immunoglobulin (BcR IG). Antigen selection is key to the pathogenesis of CLL, as evidenced by the remarkable skewing of the BcR IG gene repertoire, culminating in BcR IG stereotypy, referring to the existence of subsets of patients with (quasi)identical BcR IG. Notably, certain of these subsets have been found to display distinct, subset-biased biological background, clinical presentation, and outcome, including the response to treatment. This points to BcR IG centrality while also emphasizing the need to dissect the signaling pathways triggered by the distinctive BcR IG expressed by different subsets, particularly those with aggressive clinical behavior. In this mini-review, we discuss the current knowledge on the implicated signaling pathways as well as the recurrent gene mutations in these pathways that characterize major aggressive stereotyped subsets. Special emphasis is given on the intertwining of BcR IG and Toll-like receptor (TLR) signaling and the molecular characterization of signaling activation, which has revealed novel players implicated in shaping clinical aggressiveness in CLL, e.g., the histone methyltransferase EZH2 and the transcription factor p63.<\/jats:p>","DOI":"10.3389\/fonc.2021.771454","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:51:45Z","timestamp":1635900705000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin"],"prefix":"10.3389","volume":"11","author":[{"given":"Marina","family":"Gerousi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatia","family":"Laidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Gemenetzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Chatzidimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041720","article-title":"Chronic Lymphocytic Leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2007.04.008","article-title":"Chronic Lymphocytic Leukemia","volume":"64","author":"Ghia","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-585042","article-title":"Genomic and Epigenomic Heterogeneity in Chronic Lymphocytic Leukemia","volume":"126","author":"Gui\u00e8ze","year":"2015","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL Guidelines for Diagnosis, Indications for Treatment, Response Assessment, and Supportive Management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02030.x","article-title":"Microenvironmental Influences in Chronic Lymphocytic Leukaemia: The Role of Antigen Stimulation","volume":"264","author":"Ghia","year":"2008","journal-title":"J Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3009","article-title":"Chronic Lymphocytic Leukemia B Cells Express Restricted Sets of Mutated and Unmutated Antigen Receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V Gene Mutation Status and CD38 Expression as Novel Prognostic Indicators in Chronic Lymphocytic Leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) Genes are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-600874","article-title":"Not All IGHV3-21 Chronic Lymphocytic Leukemias are Equal: Prognostic Considerations","volume":"125","author":"Baliakas","year":"2015","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651125","article-title":"Long-Term Remissions After FCR Chemoimmunotherapy in Previously Untreated Patients With CLL: Updated Results of the CLL8 Trial","volume":"127","author":"Fischer","year":"2016","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0602-x","article-title":"Long-Term Efficacy and Safety of First-Line Ibrutinib Treatment for Patients With CLL\/SLL: 5 Years of Follow-Up From the Phase 3 RESONATE-2 Study","volume":"34","author":"Burger","year":"2020","journal-title":"Leukemia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.322","article-title":"Antigen Receptor Stereotypy in Chronic Lymphocytic Leukemia","volume":"31","author":"Stamatopoulos","year":"2017","journal-title":"Leukemia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.2262","article-title":"Somatically Mutated Ig VH3-21 Genes Characterize a New Subset of Chronic Lymphocytic Leukemia","volume":"99","author":"Tobin","year":"2002","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3485","article-title":"Chronic Lymphocytic Leukemias Utilizing the VH3-21 Gene Display Highly Restricted V\u03bb2-14 Gene Use and Homologous CDR3s: Implicating Recognition of a Common Antigen Epitope","volume":"101","author":"Tobin","year":"2003","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-051110","article-title":"Comprehensive Characterization of IGHV3-21\u2013Expressing B-Cell Chronic Lymphocytic Leukemia: An Italian Multicenter Study","volume":"109","author":"Bomben","year":"2006","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-099564","article-title":"Stereotyped Patterns of Somatic Hypermutation in Subsets of Patients With Chronic Lymphocytic Leukemia: Implications for the Role of Antigen Selection in Leukemogenesis","volume":"111","author":"Murray","year":"2008","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of Patients With Chronic Lymphocytic Leukemia Carry Stereotyped Receptors: Pathogenetic Implications and Clinical Correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040544","article-title":"Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia","volume":"200","author":"Messmer","year":"2004","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0132","article-title":"Subsets With Restricted Immunoglobulin Gene Rearrangement Features Indicate a Role for Antigen Selection in the Development of Chronic Lymphocytic Leukemia","volume":"104","author":"Tobin","year":"2004","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0818","article-title":"Chronic Lymphocytic Leukemia B Cells of More Than 1% of Patients Express Virtually Identical Immunoglobulins","volume":"104","author":"Widhopf GF","year":"2004","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1511","article-title":"Immunoglobulin Light Chain Repertoire in Chronic Lymphocytic Leukemia","volume":"106","author":"Stamatopoulos","year":"2005","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535751","article-title":"IGHV Gene Insertions and Deletions in Chronic Lymphocytic Leukemia: \u201cCLL-Biased\u201d Deletions in a Subset of Cases With Stereotyped Receptors","volume":"36","author":"Belessi","year":"2006","journal-title":"Eur J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-393694","article-title":"Stereotyped B-Cell Receptors in One-Third of Chronic Lymphocytic Leukemia: A Molecular Classification With Implications for Targeted Therapies","volume":"119","author":"Agathangelidis","year":"2012","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.186","article-title":"A Different Ontogenesis for Chronic Lymphocytic Leukemia Cases Carrying Stereotyped Antigen Receptors: Molecular and Computational Evidence","volume":"24","author":"Darzentas","year":"2010","journal-title":"Leukemia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007039","article-title":"Higher-Order Connections Between Stereotyped Subsets: Implications for Improved Patient Classification in CLL","volume":"137","author":"Agathangelidis","year":"2021","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-166868","article-title":"Evidence for the Significant Role of Immunoglobulin Light Chains in Antigen Recognition and Selection in Chronic Lymphocytic Leukemia","volume":"113","author":"Hadzidimitriou","year":"2009","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-603217","article-title":"Excessive Antigen Reactivity may Underlie the Clinical Aggressiveness of Chronic Lymphocytic Leukemia Stereotyped Subset 8","volume":"125","author":"Gounari","year":"2015","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12859-018-2381-1","article-title":"Automated Shape-Based Clustering of 3D Immunoglobulin Protein Structures in Chronic Lymphocytic Leukemia","volume":"19","author":"Polychronidou","year":"2018","journal-title":"BMC Bioinf"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.021014","article-title":"High-Density Screening Reveals a Different Spectrum of Genomic Aberrations in Chronic Lymphocytic Leukemia Patients With \u201cStereotyped\u201d IGHV3-21 and IGHV4-34 B-Cell Receptors","volume":"95","author":"Marincevic","year":"2010","journal-title":"Haematologica"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.028639","article-title":"Distinct Gene Expression Profiles in Subsets of Chronic Lymphocytic Leukemia Expressing Stereotyped IGHV4-34 B-Cell Receptors","volume":"95","author":"Marincevic","year":"2010","journal-title":"Haematologica"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4161\/epi.22901","article-title":"Distinct Transcriptional Control in Major Immunogenetic Subsets of Chronic Lymphocytic Leukemia Exhibiting Subset-Biased Global DNA Methylation Profiles","volume":"7","author":"Kanduri","year":"2012","journal-title":"Epigenetics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.044792","article-title":"Toll-Like Receptor Signaling Pathway in Chronic Lymphocytic Leukemia: Distinct Gene Expression Profiles of Potential Pathogenic Significance in Specific Subsets of Patients","volume":"96","author":"Arvaniti","year":"2011","journal-title":"Haematologica"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2011.00480","article-title":"Distinct Innate Immunity Pathways to Activation and Tolerance in Subgroups of Chronic Lymphocytic Leukemia With Distinct Immunoglobulin Receptors","volume":"18","author":"Ntoufa","year":"2012","journal-title":"Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature11309","article-title":"Chronic Lymphocytic Leukaemia is Driven by Antigen-Independent Cell-Autonomous Signalling","volume":"489","author":"Minden","year":"2012","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.231027","article-title":"Prognostic Impact of Prevalent Chronic Lymphocytic Leukemia Stereotyped Subsets: Analysis Within Prospective Clinical Trials of the German CLL Study Group (GCLLSG)","volume":"105","author":"Jaramillo","year":"2020","journal-title":"Haematologica"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005216","article-title":"Higher-Order Immunoglobulin Repertoire Restrictions in CLL: The Illustrative Case of Stereotyped Subsets 2 and 169","volume":"137","author":"Gemenetzi","year":"2021","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.125","article-title":"Immunoglobulin Gene Sequence Analysis in Chronic Lymphocytic Leukemia: Updated ERIC Recommendations","volume":"31","author":"Rosenquist","year":"2017","journal-title":"Leukemia"},{"key":"B38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","article-title":"Molecular and Clinical Features of Chronic Lymphocytic Leukaemia With Stereotyped B Cell Receptors: Results From an Italian Multicentre Study","volume":"144","author":"Bomben","year":"2009","journal-title":"Br J Haematol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ajh.23591","article-title":"Stereotyped Subset 1 Chronic Lymphocytic Leukemia: A Direct Link Between B-Cell Receptor Structure, Function, and Patients\u2019 Prognosis","volume":"89","author":"Giudice","year":"2014","journal-title":"Am J Hematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(14)00005-2","article-title":"Clinical Effect of Stereotyped B-Cell Receptor Immunoglobulins in Chronic Lymphocytic Leukaemia: A Retrospective Multicentre Study","volume":"1","author":"Baliakas","year":"2014","journal-title":"Lancet Haematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.141812","article-title":"Different Spectra of Recurrent Gene Mutations in Subsets of Chronic Lymphocytic Leukemia Harboring Stereotyped B-Cell Receptors","volume":"101","author":"Sutton","year":"2016","journal-title":"Haematologica"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20142009","article-title":"Functional Loss of I\u03bab\u03f5 Leads to NF-\u03bab Deregulation in Aggressive Chronic Lymphocytic Leukemia","volume":"212","author":"Mansouri","year":"2015","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2013.00005","article-title":"Differential microRNA Profiles and Their Functional Implications in Different Immunogenetic Subsets of Chronic Lymphocytic Leukemia","volume":"19","author":"Papakonstantinou","year":"2013","journal-title":"Mol Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030262","article-title":"Inhibition of EZH2 and Immune Signaling Exerts Synergistic Antitumor Effects in Chronic Lymphocytic Leukemia","volume":"3","author":"Chartomatsidou","year":"2019","journal-title":"Blood Adv"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2019.1633867","article-title":"EZH2 Upregulates the PI3K\/AKT Pathway Through IGF1R and MYC in Clinically Aggressive Chronic Lymphocytic Leukaemia","volume":"14","author":"Kosalai","year":"2019","journal-title":"Epigenetics"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15746","article-title":"Distinct Homotypic B-Cell Receptor Interactions Shape the Outcome of Chronic Lymphocytic Leukaemia","volume":"8","author":"Minici","year":"2017","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.182634","article-title":"No Improvement in Long-Term Survival Over Time for Chronic Lymphocytic Leukemia Patients in Stereotyped Subsets 1 and 2 Treated With Chemo(Immuno)Therapy","volume":"103","author":"Baliakas","year":"2018","journal-title":"Haematologica"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.98","article-title":"Distinct Patterns of Novel Gene Mutations in Poor-Prognostic Stereotyped Subsets of Chronic Lymphocytic Leukemia: The Case of SF3B1 and Subset 2","volume":"27","author":"Strefford","year":"2013","journal-title":"Leukemia"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-486209","article-title":"Association Between Molecular Lesions and Specific B-Cell Receptor Subsets in Chronic Lymphocytic Leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12893","article-title":"The Frequency of TP53 Gene Defects Differs Between Chronic Lymphocytic Leukaemia Subgroups Harbouring Distinct Antigen Receptors","volume":"166","author":"Malcikova","year":"2014","journal-title":"Br J Haematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.142968","article-title":"ATM Mutations in Major Stereotyped Subsets of Chronic Lymphocytic Leukemia: Enrichment in Subset #2 is Associated With Markedly Short Telomeres","volume":"101","author":"Navrkalova","year":"2016","journal-title":"Haematologica"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003707","article-title":"Spliceosome Structure and Function","volume":"3","author":"Will","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0133","article-title":"The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study","volume":"24","author":"Stamatopoulos","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1913810117","article-title":"IGLV3-21*01 is an Inherited Risk Factor for CLL Through the Acquisition of a Single-Point Mutation Enabling Autonomous BCR Signaling","volume":"117","author":"Maity","year":"2020","journal-title":"PNAS"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31999","article-title":"Integrated Epigenomic and Transcriptomic Analysis Reveals TP63 as a Novel Player in Clinically Aggressive Chronic Lymphocytic Leukemia","volume":"144","author":"Papakonstantinou","year":"2019","journal-title":"Int J Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3535","article-title":"Interleukin-21 Receptor (IL-21R) is Up-Regulated by CD40 Triggering and Mediates Proapoptotic Signals in Chronic Lymphocytic Leukemia B Cells","volume":"107","author":"de Totero","year":"2006","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0283","article-title":"ATM, CTLA4, MNDA, and HEM1 in High Versus Low CD38 Expressing B-Cell Chronic Lymphocytic Leukemia","volume":"13","author":"Joshi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e70352","DOI":"10.1371\/journal.pone.0070352","article-title":"Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia","volume":"8","author":"Mittal","year":"2013","journal-title":"PloS One"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic Lymphocytic Leukemia Antibodies With a Common Stereotypic Rearrangement Recognize Nonmuscle Myosin Heavy Chain IIA","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419399","article-title":"Remarkably Similar Antigen Receptors Among a Subset of Patients With Chronic Lymphocytic Leukemia","volume":"113","author":"Ghiotto","year":"2004","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1993","article-title":"IgG-Switched CLL has a Distinct Immunogenetic Signature From the Common MD Variant: Ontogenetic Implications","volume":"20","author":"Vardi","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3446","article-title":"P63 Steps Into the Limelight: Crucial Roles in the Suppression of Tumorigenesis and Metastasis","volume":"13","author":"Su","year":"2013","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.771454\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:51:52Z","timestamp":1635900712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.771454\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,3]]},"references-count":62,"alternative-id":["10.3389\/fonc.2021.771454"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.771454","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,3]]},"article-number":"771454"}}